TY - JOUR AU - Mangano, D. T. AU - Tudor, I. C. AU - Dietzel, C. PY - 2006 DA - 2006// TI - The risk associated with aprotinin in cardiac surgery JO - N Engl J Med VL - 354 UR - https://doi.org/10.1056/NEJMoa051379 DO - 10.1056/NEJMoa051379 ID - Mangano2006 ER - TY - JOUR AU - Cosgrove, D. M. AU - Heric, B. AU - Lytle, B. W. AU - Taylor, P. C. AU - Novoa, R. AU - Golding, L. A. AU - Stewart, R. W. AU - McCarthy, P. M. AU - Loop, F. D. PY - 1992 DA - 1992// TI - Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study JO - Ann Thorac Surg VL - 54 UR - https://doi.org/10.1016/0003-4975(92)90066-D DO - 10.1016/0003-4975(92)90066-D ID - Cosgrove1992 ER - TY - JOUR AU - D'Ambra, M. N. AU - Akins, C. W. AU - Blackstone, E. H. AU - Bonney, S. L. AU - Cohn, L. H. AU - Cosgrove, D. M. AU - Levy, J. H. AU - Lynch, K. E. AU - Maddi, R. PY - 1996 DA - 1996// TI - Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial JO - J Thorac Cardiovasc Surg VL - 112 UR - https://doi.org/10.1016/S0022-5223(96)70110-1 DO - 10.1016/S0022-5223(96)70110-1 ID - D'Ambra1996 ER - TY - JOUR AU - Feindt, P. R. AU - Walcher, S. AU - Volkmer, I. AU - Keller, H. E. AU - Straub, U. AU - Huwer, H. AU - Seyfert, U. T. AU - Petzold, T. AU - Gams, E. PY - 1995 DA - 1995// TI - Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting JO - Ann Thorac Surg VL - 60 UR - https://doi.org/10.1016/0003-4975(95)00525-P DO - 10.1016/0003-4975(95)00525-P ID - Feindt1995 ER - TY - JOUR AU - Sundt, T. M. AU - Kouchoukos, N. T. AU - Saffitz, J. E. AU - Murphy, S. F. AU - Wareing, T. H. AU - Stahl, D. J. PY - 1993 DA - 1993// TI - Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest JO - Ann Thorac Surg VL - 55 UR - https://doi.org/10.1016/0003-4975(93)91082-X DO - 10.1016/0003-4975(93)91082-X ID - Sundt1993 ER - TY - JOUR AU - Umbrain, V. AU - Christiaens, F. AU - Camu, F. PY - 1994 DA - 1994// TI - Intraoperative coronary thrombosis: can aprotinin and protamine be incriminated? JO - J Cardiothorac Vasc Anesth VL - 8 UR - https://doi.org/10.1016/1053-0770(94)90062-0 DO - 10.1016/1053-0770(94)90062-0 ID - Umbrain1994 ER - TY - JOUR AU - Karkouti, K. AU - Beattie, W. S. AU - Dattilo, K. M. AU - McCluskey, S. A. AU - Ghannam, M. AU - Hamdy, A. AU - Wijeysundera, D. N. AU - Fedorko, L. AU - Yau, T. M. PY - 2006 DA - 2006// TI - A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery JO - Transfusion VL - 46 UR - https://doi.org/10.1111/j.1537-2995.2006.00724.x DO - 10.1111/j.1537-2995.2006.00724.x ID - Karkouti2006 ER - TY - STD TI - Hughes S: Aprotinin safety again in spotlight as new study suggests increased cardiac events.Medscape Heartwire October 2, 2006 [http://www.medscape.com/viewarticle/545400] UR - http://www.medscape.com/viewarticle/545400 ID - ref8 ER - TY - STD TI - Harris G: FDA says Bayer failed to reveal drug risk study.New York Times September 30, 2006 [http://www.nytimes.com/2006/09/30/health/30fda.html] UR - http://www.nytimes.com/2006/09/30/health/30fda.html ID - ref9 ER - TY - STD TI - US Food and Drug Administration: FDA Public Health Advisory: Aprotinin Injection (marketed as Trasylol).[http://www.fda.gov/cder/drug/advisory/aprotinin20060929.htm] UR - http://www.fda.gov/cder/drug/advisory/aprotinin20060929.htm ID - ref10 ER -